SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | n/a |
Enterprise Value ($M) | n/a |
Book Value ($M) | 17.05 |
Book Value / Share | 0.37 |
Price / Book | n/a |
NCAV ($M) | 4.25 |
NCAV / Share | 0.09 |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -2.50 |
Return on Assets (ROA) | -0.40 |
Return on Equity (ROE) | -1.96 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 4.56 |
Current Ratio | 4.56 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 81.02 |
Assets | 93.82 |
Liabilities | 76.77 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 25.38 |
Operating Income | -49.60 |
Net Income | -43.27 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -39.35 |
Cash from Investing | 16.43 |
Cash from Financing | 25.16 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Goldman Sachs Group Inc | 2.20 | ||
13G/A | Artal International S.C.A. | 7.80 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
16,063 | 113,862 | 14.11 | |
29,835 | 40,104 | 74.39 | |
26,141 | 171,024 | 15.28 | |
23,573 | 142,523 | 16.54 | |
(click for more detail) |
Similar Companies | |
---|---|
ACAB – Atlantic Coastal Acquisition Corp. II | ACET – Adicet Bio, Inc. |
ACIU – AC Immune SA | ACRV – Acrivon Therapeutics, Inc. |
ADMA – ADMA Biologics, Inc. |
Financial data and stock pages provided by
Fintel.io